Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Br J Dermatol ; 184(6): 1113-1122, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33236347

RESUMEN

BACKGROUND: The lack of uniformity in the outcomes reported in clinical studies of the treatment of cutaneous squamous cell carcinoma (cSCC) complicates efforts to compare treatment effectiveness across trials. OBJECTIVES: To develop a core outcome set (COS), a minimum set of agreed-upon outcomes to be measured in all clinical trials of a given disease or outcome, for the treatment of cSCC. METHODS: One hundred and nine outcomes were identified via a systematic literature review and interviews with 28 stakeholders. After consolidation of this long list, 55 candidate outcomes were rated by 19 physician and 10 patient stakeholders, in two rounds of Delphi exercises. Outcomes scored 'critically important' (score of 7, 8 or 9) by ≥ 70% of patients and ≥ 70% of physicians were provisionally included. At the consensus meeting, after discussion and voting of 44 international experts and patients, the provisional list was reduced to a final core set, for which consensus was achieved among all meeting participants. RESULTS: A core set of seven outcomes was finalized at the consensus meeting: (i) serious or persistent adverse events, (ii) patient-reported quality of life, (iii) complete response, (iv) partial response, (v) recurrence-free survival, (vi) progression-free survival and (vii) disease-specific survival. CONCLUSIONS: In order to increase the comparability of results across trials and to reduce selective reporting bias, cSCC researchers should consider reporting these core outcomes. Further work needs to be performed to identify the measures that should be reported for each of these outcomes.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias Cutáneas , Carcinoma de Células Escamosas/terapia , Técnica Delphi , Humanos , Calidad de Vida , Proyectos de Investigación , Neoplasias Cutáneas/terapia , Resultado del Tratamiento
2.
Proc Biol Sci ; 284(1848)2017 02 08.
Artículo en Inglés | MEDLINE | ID: mdl-28179513

RESUMEN

White-nose syndrome (WNS) is a fungal disease responsible for decimating many bat populations in North America. Pseudogymnoascus destructans (Pd), the psychrophilic fungus responsible for WNS, prospers in the winter habitat of many hibernating bat species. The immune response that Pd elicits in bats is not yet fully understood; antibodies are produced in response to infection by Pd, but they may not be protective and indeed may be harmful. To understand how bats respond to infection during hibernation, we studied the effect of Pd inoculation on the survival and gene expression of captive hibernating Myotis lucifugus with varying pre-hibernation antifungal antibody titres. We investigated gene expression through the transcription of selected cytokine genes (Il6, Il17a, Il1b, Il4 and Ifng) associated with inflammatory, Th1, Th2 and Th17 immune responses in wing tissue and lymph nodes. We found no difference in survival between bats with low and high anti-Pd titres, although anti-Pd antibody production during hibernation differed significantly between infected and uninfected bats. Transcription of Il6 and Il17a was higher in the lymph nodes of infected bats compared with uninfected bats. Increased transcription of these cytokines in the lymph node suggests that a pro-inflammatory immune response to WNS is not restricted to infected tissues and occurs during hibernation. The resulting Th17 response may be protective in euthermic bats, but because it may disrupt torpor, it could be detrimental during hibernation.


Asunto(s)
Quirópteros/inmunología , Hibernación/inmunología , Micosis/veterinaria , Animales , Ascomicetos , Quirópteros/microbiología , Citocinas/inmunología , Micosis/inmunología , América del Norte , Células Th17/inmunología
3.
N Z Med J ; 88(625): 433-5, 1978 Dec 13.
Artículo en Inglés | MEDLINE | ID: mdl-281636

RESUMEN

Continuous portable 24-hour tape recorded monitoring of the electrocardiogram in 189 healthy adults was used to provide data about dysrhythmia during normal daily activity. The age of the subjects ranged from 20 to 70 years and the mean age was 44. One hundred and forty-eight were less than 50 years of age. Dysrhythmia, mainly asymptomatic, occurred in 71 subjects (37 percent). In 31 (16 percent) it was ventricular, in 20 (10.5 percent) it was supraventricular and in a further 20 (10.5 percent) it was combined. In 12 (6.3 percent) ventricular ectopy was considered potentially serious. It was not more prevalent in smokers. This study shows a lesser number of normal subjects with dysrhythmia than in most other reported studies.


Asunto(s)
Arritmias Cardíacas/epidemiología , Actividades Cotidianas , Adulto , Anciano , Arritmias Cardíacas/diagnóstico , Ritmo Circadiano , Electrocardiografía , Femenino , Sistema de Conducción Cardíaco/fisiopatología , Frecuencia Cardíaca , Humanos , Masculino , Persona de Mediana Edad , Monitoreo Fisiológico , Fumar/fisiopatología , Grabación en Cinta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA